13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2023-12-11 Event — SEC 0001193125-23-292713 →

Fairmount Funds Management LLC Spyre Therapeutics, Inc. SYRE

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
55 transactions
0 buys · 44 sales · 9 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
20 filings by this filer
19 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 9.69
11,859,975 shares short · +0.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $21.70M
Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-02 King-Jones Heidy officer Option exercise 400 $14.50 $6K
2026-09-02 King-Jones Heidy officer Sale 400 $90.00 $36K
2026-09-02 Burrows Scott L officer Sale 18,232 $89.35 $1.63M
2026-09-01 King-Jones Heidy officer Option exercise 27,999 $14.50 $406K
2026-09-01 King-Jones Heidy officer Sale 4,845 $86.40 $419K
2026-09-01 King-Jones Heidy officer Sale 16,548 $87.20 $1.44M
2026-09-01 King-Jones Heidy officer Sale 6,206 $88.17 $547K
2026-09-01 King-Jones Heidy officer Sale 400 $89.38 $36K
2026-09-01 Burrows Scott L officer Option exercise 7,500 $14.50 $109K
2026-09-01 Burrows Scott L officer Sale 900 $86.25 $78K
2026-09-01 Burrows Scott L officer Sale 4,384 $87.11 $382K
2026-09-01 Burrows Scott L officer Sale 2,016 $88.03 $177K
2026-09-01 Burrows Scott L officer Sale 200 $89.04 $18K
2026-09-01 Turtle Cameron director, officer Sale 2,500 $86.36 $216K
2026-09-01 Turtle Cameron director, officer Sale 8,400 $87.15 $732K
2026-09-01 Turtle Cameron director, officer Sale 3,700 $88.06 $326K
2026-09-01 Turtle Cameron director, officer Sale 400 $89.07 $36K
2026-08-07 Albers Jeffrey W. director Option exercise 5,000 $10.39 $52K
2026-08-07 Albers Jeffrey W. director Sale 5,000 $104.47 $522K
2026-08-07 Albers Jeffrey W. director Sale 8,000 $104.38 $835K
2026-08-07 Albers Jeffrey W. director Sale 10,000 $104.68 $1.05M
2026-08-03 Burrows Scott L officer Option exercise 7,500 $14.50 $109K
2026-08-03 Burrows Scott L officer Sale 5,100 $95.21 $486K
2026-08-03 Burrows Scott L officer Sale 2,300 $96.30 $221K
2026-08-03 Burrows Scott L officer Sale 100 $97.10 $10K
Showing 25 of 55

Other 13D/G Filings on Spyre Therapeutics, Inc.

FiledFormFilerStakeShares
2026-06-23 SCHEDULE 13D/A Fairmount Funds Management LLC 8,835,440 view →
2022-02-10 SC BAKER BROS. ADVISORS LP view →
2021-03-19 SC BAKER BROS. ADVISORS LP view →

Other Filings by Fairmount Funds Management LLC

FiledFormIssuerStakeShares
2026-09-11 SCHEDULE 13D Korsana Biosciences, Inc. 19.99% 9,103,729 view →
2026-09-03 SCHEDULE 13D/A Apogee Therapeutics, Inc. 0 view →
2026-07-20 SCHEDULE 13D/A Crescent Biopharma, Inc. 6,593,385 view →
2026-07-01 SCHEDULE 13D/A ORUKA THERAPEUTICS, INC. ORKA 19.50% 14,553,895 view →
2026-06-23 SCHEDULE 13D/A SPYRE THERAPEUTICS, INC. SYRE 8,835,440 view →
2026-06-23 SCHEDULE 13D/A Apogee Therapeutics, Inc. APGE 9.99% 6,713,519 view →
2026-06-09 SCHEDULE 13D/A Jade Biosciences, Inc. JBIO 19.99% 14,069,494 view →
2026-05-13 SCHEDULE 13D/A Viridian Therapeutics, Inc.\DE VRDN 17,201,800 view →
2026-01-22 SCHEDULE Apogee Therapeutics, Inc. APGE 9.99% 6,047,027 view →
2026-01-22 SCHEDULE Cogent Biosciences, Inc. COGT 9.90% 16,261,918 view →
2025-10-14 SCHEDULE Apogee Therapeutics, Inc. APGE 9.99% 5,776,881 view →
2025-09-15 SCHEDULE Dianthus Therapeutics, Inc. /DE/ DNTH 9.90% 4,052,052 view →
2025-03-10 SCHEDULE Oruka Therapeutics, Inc. ORKA 19.99% 8,511,824 view →
2024-04-01 SC Cogent Biosciences, Inc. COGT view →
2024-04-01 SC Dianthus Therapeutics, Inc. /DE/ DNTH view →
2024-04-01 SC Viridian Therapeutics, Inc.\DE VRDN view →
2024-04-01 SC Apogee Therapeutics, Inc. APGE view →
2023-06-13 SC Cogent Biosciences, Inc. COGT view →
2021-09-23 SC Viridian Therapeutics, Inc.\DE VRDN view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →